Hemolysis Following Intraoperative Cell Salvage Replacement in a Scoliosis Patient With Sickle Cell Trait

You, Daniel; Peiro-Garcia, Alejandro; Ferri-de-Barros, Fabio; Parsons, David

doi:10.1097/brs.0000000000002211

Cited by 8 publications

(7 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The use of IBSA is indicated in LT because the possibility of bleeding exceeding 20% of total blood volume is anticipated[46], being considered safe and cost-effective. Although the use of IBSA should be encouraged, concerns remain about the safety of IBSA in specific scenarios, such as the treatment of liver tumors with intraperitoneal rupture[56] and in patients with sickle cell anemia.…”

Section: Resultsmentioning

confidence: 99%

“…Sickle cell anemia is a relative contraindication to IBSA utilization[46]. The presence of sickle cell trait, in turn, is still a matter of debate.…”

Section: Disadvantages Of Ibsamentioning

confidence: 99%

“…The presence of sickle cell trait, in turn, is still a matter of debate. A case series suggested that IBSA is a safe practice in this group of patients[46].…”

Section: Disadvantages Of Ibsamentioning

confidence: 99%

See 2 more Smart Citations

Intraoperative cell salvage with autologous transfusion in liver transplantation

Pinto

Chedid

Sekine

et al. 2019

WJGS

View full text Add to dashboard Cite

Liver transplant (LT) is the primary treatment for patients with end-stage liver disease. About 25000 LTs are performed annually in the world. The potential for intraoperative bleeding is quite variable. However, massive bleeding is common and requires blood transfusion. Allogeneic blood transfusion has an immunosuppressive effect and an impact on recipient survival, in addition to the risk of transmission of viral infections and transfusion errors, among others. Techniques to prevent excessive bleeding or to use autologous blood have been proposed to minimize the negative effects of allogeneic blood transfusion. Intraoperative reinfusion of autologous blood is possible through previous self-donation or blood collected during the operation. However, LT does not normally allow autologous transfusion by prior self-donation. Hence, using autologous blood collected intraoperatively is the most feasible option. The use of intraoperative blood salvage autotransfusion (IBSA) minimizes the perioperative use of allogeneic blood, preventing negative transfusion effects without negatively impacting other clinical outcomes. The use of IBSA in patients with cancer is still a matter of debate due to the theoretical risk of reinfusion of tumor cells. However, studies have demonstrated the safety of IBSA in several surgical procedures, including LT for hepatocellular carcinoma. Considering the literature available to date, we can state that IBSA should be routinely used in LT, both in patients with cancer and in patients with benign diseases.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Sickle cell anemia is a relative contraindication to IBSA utilization[46]. The presence of sickle cell trait, in turn, is still a matter of debate.…”

Section: Disadvantages Of Ibsamentioning

confidence: 99%

See 1 more Smart Citation

Intraoperative cell salvage with autologous transfusion in liver transplantation

Pinto

Chedid

Sekine

et al. 2019

WJGS

View full text Add to dashboard Cite

show abstract

“…The risk of haemolysis increases with the presence of free radicals and a concentration of free Hb > 5 mol/L. Pressurizing blood for reinfusion at a higher rate is not indicated [15,16,24,25]. There is a potential risk of air or amniotic fluid embolism, dilutional coagulopathy, protein loss, septic contamination and disseminated infection, transfusion of activated platelets and clotting factors and activated polymorphonuclear leukocytes.…”

Section: Safety and Quality Considerations Of Icsmentioning

confidence: 99%

Cell Salvage in Oncological Surgery, Peripartum Haemorrhage and Trauma

2022

View full text Add to dashboard Cite

Oncological surgery, obstetric haemorrhage and severe trauma are the most challenging conditions for establishing clinical recommendations for the use of cell salvage. When the likelihood of allogeneic transfusion is high, the intraoperative use of this blood-saving technique would be justified, but specific patient selection criteria are needed. The main concerns in the case of oncological surgery are the reinfusion of tumour cells, thereby increasing the risk of metastasis. This threat could be minimized, which may help to rationalize its indication. In severe peripartum haemorrhage, cell salvage has not proven cost-effective, damage control techniques have been developed, and, given the risk of fetomaternal alloimmunization and amniotic fluid embolism, it is increasingly out of use. In trauma, bleeding may originate from multiple sites, coagulopathy may develop, and it should be evaluated whether re-transfusion of autologous blood collected from uncontaminated organ cavities would be feasible. General safety measures include washing recovered blood and its passage through leukocyte depletion filters. To date, no well-defined indications for cell salvage have been established for these pathologies, but with accurate case selection and selective implementation, it could become safe and effective. Randomized clinical trials are urgently needed.

show abstract

“…Относительно редко, но в результате РК возможно развитие гемолиза в реинфузате с последующей гематурией и даже острым почечным повреждением [41][42][43]. Его развитию могут способствовать вполне очевидные факторы, такие как механическое повреждение эритроцитов роликовыми насосами, контакт крови с магистралями контура селл-сейвера, высокие цифры разряжения в отсосе, разрушающий эффект УЗИ-аспираторов.…”

Section: осложнения методики реинфузии кровиunclassified

Blood reinfusion in surgery. State of art. Review

Lubnin

Gromova

2019

Annals of Critical Care

View full text Add to dashboard Cite

В работе на основании данных литературы и собственного опыта анализируется современное состояние проблемы реинфузии крови в хирургии. Рассмотрены технические решения, методические подходы, аппаратура для проведения реинфузии крови у хирургических больных. Также рассмотрены такие аспекты проблемы, как показания, противопоказания и особенности применения методики в различных областях хирургии. Ключевые слова: реинфузия крови в хирургии, технические решения, показания и противопоказания, возможные осложнения u Для корреспонденции: Лубнин Андрей Юрьевичд-р мед. наук, профессор, руководитель отдела анестезиологии, реанимации и интенсивной терапии ФГАУ «НМИЦ нейрохирургии им. акад. Н.Н. Бурденко» МЗ РФ,

show abstract

Hemolysis Following Intraoperative Cell Salvage Replacement in a Scoliosis Patient With Sickle Cell Trait

Abstract: 5.

Cited by 8 publications

References 12 publications

Intraoperative cell salvage with autologous transfusion in liver transplantation

Intraoperative cell salvage with autologous transfusion in liver transplantation

Cell Salvage in Oncological Surgery, Peripartum Haemorrhage and Trauma

Blood reinfusion in surgery. State of art. Review

Contact Info

Product

Resources

About